| Medical and Health Sciences | Lifetime | 204 | US 111 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 138 | US 55 | 99.97 |
| Nephrology | Lifetime | 5 | US 3 | 99.97 |
| Cardiology and Cardiovascular Medicine | Lifetime | 261 | US 153 | 99.66 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 355 | US 198 | 98.93 |
| Nephrology | 2021-2025 | 16 | US 6 | 99.68 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 139 | US 67 | 99.30 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 166 | US 75 | 97.18 |
| Public, Environmental and Occupational Health | 2021-2025 | 516 | US 197 | 95.02 |
| Epidemiology | 2021-2025 | 657 | US 233 | 93.83 |
| Medical Physiology | 2021-2025 | 470 | US 175 | 93.13 |
| Surgery | 2021-2025 | 891 | US 342 | 91.82 |
| Psychiatry and Mental health | 2021-2025 | 329 | US 124 | 91.72 |
| Genetics | 2021-2025 | 440 | US 162 | 88.08 |
| Rheumatology | 2021-2025 | 422 | US 136 | 79.97 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 902 | US 308 | 76.74 |
| Chronic Kidney Disease and Diabetes | Lifetime | 2 | US 1 | 99.98 |
| Dialysis and Renal Disease Management | Lifetime | 4 | US 4 | 99.97 |
| Blood Pressure and Hypertension Studies | Lifetime | 24 | US 13 | 99.84 |
| Renal and Vascular Pathologies | Lifetime | 18 | US 15 | 99.69 |
| Renal Diseases and Glomerulopathies | Lifetime | 23 | US 15 | 99.69 |
| Acute Kidney Injury Research | Lifetime | 68 | US 34 | 98.99 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 157 | US 77 | 99.35 |
| Diabetes Treatment and Management | Lifetime | 237 | US 100 | 99.01 |
| Cardiovascular Function and Risk Factors | Lifetime | 492 | US 268 | 99.11 |
| Cardiovascular Health and Risk Factors | Lifetime | 99 | US 58 | 98.37 |
| Heart Failure Treatment and Management | Lifetime | 347 | US 169 | 98.70 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 91 | US 35 | 97.69 |
| Lipoproteins and Cardiovascular Health | Lifetime | 363 | US 180 | 98.45 |
| Diabetes Management and Research | Lifetime | 445 | US 208 | 98.44 |
| Birth, Development, and Health | Lifetime | 681 | US 264 | 98.15 |
| Nutritional Studies and Diet | Lifetime | 530 | US 214 | 98.26 |
| Peripheral Artery Disease Management | Lifetime | 389 | US 236 | 97.64 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 794 | US 343 | 98.07 |
| Erythropoietin and Anemia Treatment | Lifetime | 140 | US 60 | 97.57 |
| Potassium and Related Disorders | Lifetime | 151 | US 87 | 96.98 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 823 | US 329 | 96.78 |
| Cardiovascular Health and Disease Prevention | Lifetime | 767 | US 292 | 96.81 |
| Genetic Associations and Epidemiology | Lifetime | 593 | US 292 | 97.00 |
| Central Venous Catheters and Hemodialysis | Lifetime | 605 | US 269 | 96.14 |
| Folate and B Vitamins Research | Lifetime | 718 | US 346 | 95.46 |
| Parathyroid Disorders and Treatments | Lifetime | 610 | US 253 | 96.53 |
| Sodium Intake and Health | Lifetime | 244 | US 117 | 96.23 |
| GDF15 and Related Biomarkers | Lifetime | 486 | US 161 | 82.21 |
| Magnesium in Health and Disease | Lifetime | 688 | US 243 | 86.00 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 6 | US 3 | 99.70 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 46 | US 19 | 98.98 |
| Dialysis and Renal Disease Management | 2021-2025 | 39 | US 12 | 98.86 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 52 | US 32 | 96.66 |
| Diabetes Treatment and Management | 2021-2025 | 239 | US 88 | 97.32 |
| Diabetes Management and Research | 2021-2025 | 222 | US 115 | 96.98 |
| Diet and metabolism studies | 2021-2025 | 579 | US 169 | 94.69 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 618 | US 259 | 95.01 |
| GDF15 and Related Biomarkers | 2021-2025 | 42 | US 11 | 89.50 |
| Genetic Associations and Epidemiology | 2021-2025 | 530 | US 235 | 90.79 |
| Diabetes and associated disorders | 2021-2025 | 480 | US 179 | 91.12 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 471 | US 128 | 88.25 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 583 | US 156 | 90.00 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 586 | US 145 | 89.05 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 620 | US 157 | 84.95 |
| Parathyroid Disorders and Treatments | 2021-2025 | 490 | US 130 | 86.96 |
| Folate and B Vitamins Research | 2021-2025 | 386 | US 83 | 80.18 |
| Health, Environment, Cognitive Aging | 2021-2025 | 957 | US 405 | 76.78 |
| Nutrition, Genetics, and Disease | 2021-2025 | 620 | US 155 | 73.86 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 366 | US 100 | 72.38 |
| Sodium Intake and Health | 2021-2025 | 621 | US 149 | 66.66 |
| Potassium and Related Disorders | 2021-2025 | 694 | US 236 | 61.37 |
| Fibroblast Growth Factor Research | 2021-2025 | 796 | US 225 | 60.38 |
| Apelin-related biomedical research | 2021-2025 | 341 | US 55 | 59.06 |
| Magnesium in Health and Disease | 2021-2025 | 770 | US 158 | 32.50 |
| Renin-Angiotensin System Studies | 2021-2025 | 892 | US 268 | 27.58 |
